Search results
Results from the WOW.Com Content Network
She has received many prestigious awards and fellowships for her numerous contributions to biochemistry and genetics, and is most famous for her work on CRISPR-Cas9 genome editing technology. [2] Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry "for the development of a method for genome editing."
In 2015, together with Emmanuelle Charpentier, she received the Breakthrough Prize in Life Sciences for her contributions to CRISPR/Cas9 genome editing technology. [86] In 2016, together with Charpentier, Feng Zhang , Philippe Horvath and Rodolphe Barrangou , she received the Canada Gairdner International Award . [ 13 ]
Charpentier is best known for her Nobel-winning work of deciphering the molecular mechanisms of a bacterial immune system, called CRISPR/Cas9, and repurposing it into a tool for genome editing. In particular, she uncovered a novel mechanism for the maturation of a non-coding RNA which is pivotal in the function of CRISPR/Cas9.
The Nobel Prize in chemistry is awarded to Jennifer Doudna of UC Berkeley and Emmanuelle Charpentier for their work on the CRISPR gene-editing tool.
In his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for future health crises and how gene editing with CRISPR factors in.
The CRISPR-Cas9 genome editing technique was a significant contributor to the Nobel Prize in Chemistry in 2020 being awarded to Emmanuelle Charpentier and Jennifer Doudna. [ 2 ] More technically, Cas9 is a RNA -guided DNA endonuclease enzyme associated with the Clustered Regularly Interspaced Short Palindromic Repeats ( CRISPR ) adaptive immune ...
On October 7, 2020, the Nobel Prize in Chemistry was awarded to Doudna and Charpentier for their work on developing CRISPR-Cas9 gene editing. [ 31 ] [ 32 ] Doudna was unable to attend the traditional live awards ceremony in Stockholm due to the COVID-19 pandemic, so she accepted the award at her home in Berkeley, California, and celebrations ...
CRISPR-Cas9 genome editing techniques have many potential applications. The use of the CRISPR-Cas9-gRNA complex for genome editing [10] was the AAAS's choice for Breakthrough of the Year in 2015. [11] Many bioethical concerns have been raised about the prospect of using CRISPR for germline editing, especially in human embryos. [12]